Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Domenico Albano in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
Search for other papers by Luca Ceriani in
Google Scholar
PubMed
included in the meta-analysis ( 10 ). A sensitivity analysis was performed to examine whether overall findings were robust to the chosen analysis method. Finally, the power of meta-analysis was calculated using the metapow command. Meta-analysis was
Search for other papers by Orwa Dandash in
Google Scholar
PubMed
Search for other papers by James Allebone in
Google Scholar
PubMed
Search for other papers by Adam Mirabelli in
Google Scholar
PubMed
Search for other papers by Nicholas Russell in
Google Scholar
PubMed
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Andrea Gogos in
Google Scholar
PubMed
Search for other papers by Richard A Kanaan in
Google Scholar
PubMed
showed that 28 days of treatment with 1mg of transdermal E2 patches in testosterone deplete men with prostate cancer was sufficient to restore serum E2 concentrations into the reference range reported for healthy men ( 33 ). Power analysis Based
Search for other papers by Malgorzata Fuksiewicz in
Google Scholar
PubMed
Search for other papers by Maria Kowalska in
Google Scholar
PubMed
Search for other papers by Agnieszka Kolasinska-Cwikla in
Google Scholar
PubMed
Search for other papers by Beata Kotowicz in
Google Scholar
PubMed
746 – 747 . ( https://doi.org/10.1093/annonc/mdv626 ) 21 Lv Y Han X Zhang C Fang Y Pu N Ji Y Wang D Xuefeng X Lou W . Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs . Endocrine
Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands
Search for other papers by Josephina G Kuiper in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Aline C Fenneman in
Google Scholar
PubMed
Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Elena Rampanelli in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed
Search for other papers by Myrthe P P van Herk-Sukel in
Google Scholar
PubMed
Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands
Search for other papers by Valery E P P Lemmens in
Google Scholar
PubMed
Search for other papers by Ernst J Kuipers in
Google Scholar
PubMed
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands
Search for other papers by Ron M C Herings in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
to a large number of non-cancer controls. This large sample size led to a high statistical power and hence allowed us to conduct subgroup analyses on gender and age. Furthermore, by linking this database to the cancer registry, detailed information on
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
NETest scores. Although the power for this mixed procedure is possibly too low because of the small sample size, the clinical relevance of 1 point increase in NETest score per year is negligible. Theoretically, gene expression levels among individuals
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
because of a delay in diagnosis ( 50 , 51 ). Based on these risk factors, we constructed a prognostic nomogram to accurately predict OS and compared its predictive power with that of the traditional TNM staging system. The results showed that the nomogram